CD63 and breast cancer: Moreover, recent studies in breast cancer cells have shown the release of hypothetical “non-classical” exosomes generated by amphisomes (produced by fusion of multivesicular bodies -MVB- and autophagosomes) (71–73)), lacking classical exosome markers (CD63, CD81, and CD9).